Cargando…

Molecular mechanism underlying epithelial‐mesenchymal transformation and cisplatin resistance in esophageal squamous cell carcinoma

Esophageal cancer (EC) occupies the seventh spot of the most prevalent malignancy cancer ailments worldwide and the sixth leading cause of cancer‐related death. Esophageal squamous cell carcinoma (ESCC) is also the most predominant histological subtype of EC, and cisplatin (DDP) is commonly used as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Kewei, Ma, Chenhui, Gu, Baohong, Wang, Bofang, Ma, Huanhuan, Deng, Xiaobo, Chen, Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626249/ https://www.ncbi.nlm.nih.gov/pubmed/37718469 http://dx.doi.org/10.1111/1759-7714.15094

Ejemplares similares

Epithelial-Mesenchymal Transition Gene Signature Is Associated with Neoadjuvant Chemoradiotherapy Resistance and Prognosis of Esophageal Squamous Cell Carcinoma
por: Song, Kewei, et al.
Publicado: (2022)

Association between eight hypermethylation-related genes and gastric cancer: a systematic review and meta-analysis
por: Ma, Chenhui, et al.
Publicado: (2022)

Advances in the Application of Preclinical Models in Photodynamic Therapy for Tumor: A Narrative Review
por: Yu, Rong, et al.
Publicado: (2023)

LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation
por: Cai, Rui, et al.
Publicado: (2020)

Expression of proteins associated with epithelial-mesenchymal transition in esophageal squamous cell carcinoma
por: Zhang, Tian, et al.
Publicado: (2018)

Effects of cisatracurium on epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma
por: Lv, Wenyan, et al.
Publicado: (2019)

Metformin Synergistically Enhances Cisplatin-Induced Cytotoxicity in Esophageal Squamous Cancer Cells under Glucose-Deprivation Conditions
por: Yu, Hongliang, et al.
Publicado: (2016)

LRG1 Suppresses Migration and Invasion of Esophageal Squamous Cell Carcinoma by Modulating Epithelial to Mesenchymal Transition
por: Zhang, Ninggang, et al.
Publicado: (2020)

Expression of CCR6 in esophageal squamous cell carcinoma and its effects on epithelial-to-mesenchymal transition
por: Liu, Jian, et al.
Publicado: (2017)

Serum gamma-glutamyl transpeptidase-to-platelet ratio (GPR) can predict the prognosis of hepatocellular carcinoma: a meta-analysis and systematic review
por: Ma, Chenhui, et al.
Publicado: (2022)

Role of matrix metalloproteinase-9 in transforming growth factor-β1-induced epithelial–mesenchymal transition in esophageal squamous cell carcinoma
por: Bai, Xue, et al.
Publicado: (2017)

Wdr66 is a novel marker for risk stratification and involved in epithelial-mesenchymal transition of esophageal squamous cell carcinoma
por: Wang, Qing, et al.
Publicado: (2013)

eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma
por: Liu, Ting, et al.
Publicado: (2016)

Cripto-1 Promotes the Epithelial-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma Cells
por: Huang, Chun, et al.
Publicado: (2015)

The Level of Mesenchymal-Epithelial Transition Autophosphorylation is Correlated with Esophageal Squamous Cell Carcinoma Migration
por: Taghehchian, Negin, et al.
Publicado: (2021)

Predicting malignant transformation of esophageal squamous cell lesions by combined biomarkers in an endoscopic screening program
por: Zhang, Hao, et al.
Publicado: (2016)

Photodynamic therapy improves the clinical efficacy of advanced colorectal cancer and recruits immune cells into the tumor immune microenvironment
por: Gu, Baohong, et al.
Publicado: (2022)

Construction and validation of a novel coagulation-related 7-gene prognostic signature for gastric cancer
por: Wang, Bofang, et al.
Publicado: (2022)

Detection of Epithelial-Mesenchymal Transition Status of Circulating Tumor Cells in Patients with Esophageal Squamous Carcinoma
por: Han, Dingpei, et al.
Publicado: (2018)

Aberrant methylation of EYA4 promotes epithelial‐mesenchymal transition in esophageal squamous cell carcinoma
por: Luo, Mei, et al.
Publicado: (2018)

Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells
por: Yoshioka, Masahiro, et al.
Publicado: (2017)

Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition
por: Yang, Boli, et al.
Publicado: (2021)

Concurrent cisplatin and 5-fluorouracil versus concurrent cisplatin and docetaxel with radiotherapy for esophageal squamous cell carcinoma: a propensity score-matched analysis
por: Zhang, Peng, et al.
Publicado: (2016)

Photodynamic therapy combined with bimetallic stent in the treatment of gastric cancer with malignant duodenobiliary obstruction: a case report and literature review
por: Wang, Bofang, et al.
Publicado: (2022)

Krüppel-Like Factor 4 Enhances Sensitivity of Cisplatin to Esophageal Squamous Cell Carcinoma (ESCC) Cells
por: Chen, Chuangui, et al.
Publicado: (2017)

Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance
por: Ashrafizadeh, Milad, et al.
Publicado: (2020)

Redox-dependent modulation of metformin contributes to enhanced sensitivity of esophageal squamous cell carcinoma to cisplatin
por: Li, Pin Dong, et al.
Publicado: (2017)

Prognostic significance of the epithelial-mesenchymal transition factor zinc finger E-box-binding homeobox 2 in esophageal squamous cell carcinoma
por: Huo, Xiaodong, et al.
Publicado: (2017)

Epithelial-Mesenchymal Transition and Metastasis under the Control of Transforming Growth Factor β
por: Tsubakihara, Yutaro, et al.
Publicado: (2018)

Mesenchymal Stromal Cells-Derived β2-Microglobulin Promotes Epithelial–Mesenchymal Transition of Esophageal Squamous Cell Carcinoma Cells
por: Wang, Junjie, et al.
Publicado: (2018)

PTTG1 cooperated with GLI1 leads to epithelial-mesenchymal transition in esophageal squamous cell cancer
por: Feng, Wang, et al.
Publicado: (2017)

BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial–mesenchymal transition and angiogenesis
por: Zhao, Yan, et al.
Publicado: (2021)

Corrigendum: Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition
por: Yang, Boli, et al.
Publicado: (2022)

Aberrations in ion channels interacting with lipid metabolism and epithelial–mesenchymal transition in esophageal squamous cell carcinoma
por: Parthasarathi, K. T. Shreya, et al.
Publicado: (2023)

Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis
por: Yu, Xinfang, et al.
Publicado: (2017)

Association between circ_0004365 and cisplatin resistance in esophageal squamous cell carcinoma
por: Yamada, Moyuru, et al.
Publicado: (2023)

Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma
por: Li, Pei, et al.
Publicado: (2015)

Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells
por: Wang, Yan-Yang, et al.
Publicado: (2015)

The epithelial-mesenchymal transition phenotype of metastatic lymph nodes impacts the prognosis of esophageal squamous cell carcinoma patients
por: Wen, Jing, et al.
Publicado: (2016)

Anti-metastatic effects of Aidi on human esophageal squamous cell carcinoma by inhibiting epithelial-mesenchymal transition and angiogenesis
por: Shi, Qingtong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c1c3dnpi3b3ei63sufn2om8dj6